Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2025-12-24 @ 7:58 PM
NCT ID:
NCT04156204
Eligibility Criteria:
Inclusion Criteria:
1. Age 13-22 years
2. Tanner stage 4/5
3. "Stable" kidney transplant status, as determined by the primary transplant team
4. At minimum 1 year post-kidney transplant or patients meeting all of the above inclusion criteria except 4) who have instead been transitioned to azathioprine by the primary transplant team due to intolerability of mycophenolate mofetil secondary to adverse medication effects (i.e. neutropenia, gastrointestinal intolerance etc.)
Exclusion Criteria:
1. \< Tanner stage 4
2. Kidney transplant performed at an institution other than Children's Hospital Colorado, Lurie Children's Hospital of Chicago, or Cincinnati Children's Hospital
3. Recipients of dual solid organ transplants (i.e. heart kidney, liver kidney).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
13 Years
Maximum Age:
22 Years
Study:
NCT04156204
Study Brief:
Protocol Section:
NCT04156204